These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29442013)

  • 1. P-gp modulating effect of
    Kawami M; Yamada Y; Issarachot O; Junyaprasert VB; Yumoto R; Takano M
    Pharmazie; 2018 Feb; 73(2):104-109. PubMed ID: 29442013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts.
    Takano M; Kakizoe S; Kawami M; Nagai J; Patanasethnont D; Sripanidkulchai B; Yumoto R
    Pharmazie; 2014 Nov; 69(11):823-8. PubMed ID: 25985578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells.
    Kawami M; Yumoto R; Nagai J; Junyaprasert VB; Soonthornchareonnon N; Patanasethanont D; Sripanidkulchai BO; Takano M
    Drug Metab Pharmacokinet; 2010; 25(2):155-62. PubMed ID: 20460821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
    Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
    J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
    Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
    Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
    Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study.
    Chaudhary H; Jena PK; Seshadri S
    Nutr Cancer; 2013; 65(5):775-80. PubMed ID: 23859045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G
    Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triterpenoids from the fruits of Azadirachta indica (Meliaceae).
    Kurimoto S; Takaishi Y; Ahmed FA; Kashiwada Y
    Fitoterapia; 2014 Jan; 92():200-5. PubMed ID: 24239747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion of P-gp-Mediated Drug Resistance in Ovarian Carcinoma Cells with PHPMA-Zosuquidar Conjugates.
    Battistella C; Klok HA
    Biomacromolecules; 2017 Jun; 18(6):1855-1865. PubMed ID: 28409628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
    Sun YF; Wink M
    Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.
    Yuan WQ; Zhang RR; Wang J; Ma Y; Li WX; Jiang RW; Cai SH
    Oncotarget; 2016 May; 7(21):31466-83. PubMed ID: 27129170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
    Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
    Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Melatonin on Colon Cancer Cells' Resistance to Doxorubicin in an in Vitro Study.
    Fic M; Gomulkiewicz A; Grzegrzolka J; Podhorska-Okolow M; Zabel M; Dziegiel P; Jablonska K
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28788434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.